QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $614K invested in Qualigen Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$55K
2
+$39K

Top Sellers

1
-$1.14M
2
-$150K
3
-$80.5K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$42K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$220K
2
$161K
3
$71K
4
$55K
5
$39K
6
$16K
7
$11K
8
$7K
9
$7K
10
$6K
11
$6K
12
$6K
13
$6K
14
$3K
15
–
16
–
17
–